Replies to post #6077 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Thanks Ice, at least ANI only paid $75 million + percentage of future net sales to Merck for the corti drugs. Unlike Mallickrodt who paid $5.2 billion For Questcor.

Ani can withstand a much greater price drop than Mallinckrodt. In addition a more reasonable price will probably be somewhat offset by an increase patient penetration. In 2015, only 10,000 patient were using Acthar out of a potential patient population 4,000,000.